|Table of Contents|

Analysis of the effect of PECAM1 on the migration and invasion of gastrointestinal stromal tumor cells based on single-cell transcriptome sequencing data

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 16
Page:
2961-2965
Research Field:
Publishing date:

Info

Title:
Analysis of the effect of PECAM1 on the migration and invasion of gastrointestinal stromal tumor cells based on single-cell transcriptome sequencing data
Author(s):
HU Wu1WEN Yiqiao2QIN Jialan1ZHAO Ying3ZHANG Tianbiao1
1.Department of Biochemistry and Molecular Biology,School of Life Sciences,China Medical University,Liaoning Shenyang 110122,China;2.The Third Division of Clinical Medicine,China Medical University,Liaoning Shenyang 110122,China;3.Department of Gastrointestinal Nutrition,Shengjing Hospital of China Medical University,Liaoning Shenyang 110004,China.
Keywords:
gastrointestinal stromal tumorsingle-cell transcriptome sequencingPECAM1migration and invasion
PACS:
R735.2
DOI:
10.3969/j.issn.1672-4992.2023.16.003
Abstract:
Objective:To investigate the effect of platelet and endothelial cell adhesion molecule 1(PECAM1) expression on migration and invasion ability in gastrointestinal stromal tumor(GIST) cells.Methods:The target gene was screened based on GIST single-cell transcriptome sequencing data by R language.Cells were transfected with siRNA to establish a low expression group.The effect of PECAM1 on cell migration and invasion was analyzed by wound healing assay and Transwell assay.Results:Six of eighteen GIST cell clusters were defined as non-immune cell populations based on the positive expression of PTPRC.According to the different expression levels of cancer stem cell markers CD44,CD34 and ABCB1,the non-immune cell populations were further divided into four cancer stem cell subpopulations.PECAM1 gene was screened by KEGG analysis with differential expression genes in four cancer stem cell subpopulations.Further gene set enrichment analysis showed that PECAM1 was associated with cell migration signaling pathway.Cell experiments showed that cell migration and invasion ability were significantly decreased after inhibiting expression level of PECAM1,compared to the negative control group(P<0.05).Conclusion:PECAM1 positively regulates cell migration and invasion in GIST cells.

References:

[1]SHARMA AK,KIM TS,BAUER S,et al.Gastrointestinal stromal tumor:New insights for a multimodal approach[J].Surg Oncol Clin N Am,2022,31(3):431-446.
[2]HUANG WK,WU CE,WANG SY,et al.Systemic therapy for gastrointestinal stromal tumor:Current standards and emerging challenges[J].Curr Treat Options Oncol,2022,23(9):1303-1319.
[3]SERRANO C,GEORGE S.Gastrointestinal stromal tumor:Challenges and opportunities for a new decade[J].Clin Cancer Res,2020,26(19):5078-5085.
[4]BRINCH CM,AGGERHOLM-PEDERSEN N,HOGDALL E,et al.Medical oncological treatment for patients with gastrointestinal stromal tumor(GIST)-A systematic review[J].Crit Rev Oncol Hematol,2022,172:103650.
[5]LI J,GUO S,SUN Z,et al.Noncoding RNAs in drug resistance of gastrointestinal stromal tumor[J].Front Cell Dev Biol,2022,10:808591.
[6]ARSHAD J,COSTA PA,BARRETO-COELHO P,et al.Immunotherapy strategies for gastrointestinal stromal tumor[J].Cancers(Basel),2021,13(14):3525.
[7]TAN Y,TRENT JC,WILKY BA,et al.Current status of immunotherapy for gastrointestinal stromal tumor[J].Cancer Gene Ther,2017,24(3):130-133.
[8]LIAO D,SUNDLOV J,ZHU J,et al.Atomic level dissection of the platelet endothelial cell adhesion molecule 1(PECAM-1) homophilic binding interface:Implications for endothelial cell barrier function[J].Arterioscler Thromb Vasc Biol,2022,42(2):193-204.
[9]SILVA A,PEREIRA SS,BRANDAO JR,et al.Colon tumor CD31 expression is associated with higher disease-free survival in patients with metabolic syndrome[J].Pathol Res Pract,2022,240:154182.
[10]VOCKOVA P,MOLINSKY J,KLANOVA M,et al.CD31/PECAM-1 impacts engraftment,growth and spread of mantle cell lymphoma cells and positively correlates with extramedullary involvement[J].Leuk Lymphoma,2021,62(4):861-867.
[11]BAYIK D,LATHIA JD.Cancer stem cell-immune cell crosstalk in tumour progression[J].Nat Rev Cancer,2021,21(8):526-536.
[12]SUN JH,LUO Q,LIU LL,et al.Liver cancer stem cell markers:Progression and therapeutic implications[J].World J Gastroenterol,2016,22(13):3547-3557.
[13]LIU FC,WANG Q,LI RT.Gastrointestinal stromal tumor:microenvironment characteristics and immunotherapy ideas[J].Chinese Journal of Cancer Biotherapy,2022,29(8):708-713.
[14]LIU Y,ZHANG Z,LI W,et al.PECAM1 combines with CXCR4 to trigger inflammatory cell infiltration and pulpitis progression through activating the NF-kappaB signaling pathway[J].Front Cell Dev Biol,2020,8:593653.
[15]CHEN MZ,YANG H,WANG CH,et al.Expression and significance of PECAM1 in cancer tissues of elderly patients with NSCLC[J].Journal of Clinical Pulmonary Medicine,2019,24(4):614-617.

Memo

Memo:
National Natural Science Foundation of China(No.61973316);国家自然科学基金面上项目(编号:61973316);国家自然科学基金青年基金(编号:61703435)
Last Update: 1900-01-01